Article Summary: Recent research deriving from Columbia University has found that two new drugs, currently being tested, may become suitable treatments for individuals suffering from pleural and malignant mesothelioma.
(c) Peter Kent
The second phase of a clinical trial testing mesothelioma treatments just commenced at Columbia University, according to news reports. The treatments being tested are to decrease signs and symptoms of peritoneal and malignant pleural mesothelioma, the two most dangerous forms of the disease.
Approximately 29 people will participate in the trial that may last up to six months.
Two of the drugs that will be tested include oxaliplatin and gemcitabine. According to TransWorldNews, oxaliplatin is "a platinum-containing organic compound which targets cancer cells by inhibiting or specifically preventing replication and repair of the cancer cells‚ DNA." Oxaliplatin is from Sanofi Aventis and is manufactured as Eloxatin.
The drug is commonly used in the treatment of colon and colorectal cancers, according to news reports. Gemcitabine, which is from Eli Lilly and Company is manufactured as Gemzar. The drug, according to TransWorldNews is "a cancer drug which similarly targets the replication processes of cancer cells‚ DNA by inhibiting the production of the cellular material which is necessary for DNA synthesis." Gemzar alone is used to treat patients of ovarian, lung, pancreatic and breast cancer. Combined, researchers are hoping the drugs will effectively treat and decrease mesothelioma symptoms. The Respiratory Disease Clinic in Heckeshorn in Berlin found that, "a therapy of oxapilatin and gemcitabine applied every 21 days in mesothelioma patients resulted in an increased rate of control for the disease, progression," all of which were the results of a December 2008 study."
Developing Mesothelioma
Mesothelioma is a deadly form of lung cancer that has been linked to the inhalation of asbestos fibers and asbestos dust. Asbestos is part of a mineral known as vermiculite that was heavily mined during the late 19th century and the early 20th century. It was mined across the country until the 1970s and 1980s when health and governmental regulators discovered the potential risks involved in inhaling the deadly fiber.
Although, asbestos is still abundant throughout America today, according to the U.S. government. The following are possible uses:
* thermal, electrical and sound insulation
* cement
* plastic
* resins
* filtration and liquid sterilization
* friction materials
* asbestos textiles
* paper fabrication
* flooring felts
* roofing products
* pipeline wrapping
* brake and clutch pads
Garnering Mesothelioma Assistance
It is imperative for individuals who suffer from mesothelioma to receive both legal and medical assistance from knowledgeable professionals. Because mesothelioma is often a deadly disease, receiving quality medical attention is a necessity in order to prolong the condition‚ onset and decrease the pain associated with the disease.
Additionally, it may be necessary to locate a mesothelioma attorney who can provide a free legal consultation as to the details surrounding a mesothelioma lawsuit. Because of the extreme dangers associated with the disease, it may be possible for a victim to receive monetary compensation. Speaking with a mesothelioma attorney will provide increased knowledge of a mesothelioma case.
Article Source: http://www.upublish.info
About the Author:
Peter Kent
For more information on the peanut butter recall, visit http://peanut-butter.legalview.info or http://www.LegalView.info/ . Here, individuals can also learn about other legal topics afflicting thousands of Americans including mesothelioma treatments or how to obtain a truck accident attorney.
Keywords: Peter Kent, mesothelioma, mesothelioma lawyer, mesothelioma law firm, mesothelioma attorney, mesothelioma lawsuit
**NOTE** - Peter Kent has claimed original rights on the article "University Tests New Mesothelioma Treatment" ... if there is a dispute on the originality of this article ... please contact us via our Contact Form and supply our staff with the appropriate details of dispute.
Peter Kent Article Feed : http://www.upublish.info/rssauthor/11133.xml
Author
